Each review is a PRISMA-2020-style systematic or mechanistic literature review. Click into any one to see the original research thesis, what it contributes to the body of knowledge, the full rendered text, every page as a high-resolution image, and downloadable source files. This is what we read. Read it too.
Across 34 systematic reviews and roughly 452 pages of evidence, the patterns below recur with enough consistency to act on. Hover any underlined term for the technical definition. Click any review number to verify the source.
For a horse with confirmed Type 1 PSSM, the hay should test below ten percent NSC as a percent of digestible energy. Then replace the calories you removed with fat (twelve to fifteen percent of DE), not more grain.
Adding fat without removing carbohydrate does not work. The literature supports substitution, not layering.
The patterns the research actually supports, side by side. The columns are color-coded by condition. Hover any underlined term for the technical definition. The numbers below the bold targets are the practical clinical detail; the row at the bottom links to the source reviews.
| Parameter | PSSM Type 1Genetic muscle disease (GYS1 mutation positive) | PSSM Type 2 / MFMNon-genetic muscle disease, biopsy-confirmed | EPMEquine Protozoal Myeloencephalitis (a brain & spinal cord parasite) |
|---|---|---|---|
| Hay sugar & starch limit | Below 10%Of DE. Test your hay; do not assume. | Below 12%Less strict than Type 1. Protein quality matters more here. | No specific limitQuality forage; keep the horse eating. |
| Fat in the ration | 12 to 15%Of DE. Substitute for grain, do not layer on top. | 10 to 12%Moderate. Protein quality is the bigger lever. | StandardWhatever keeps the horse eating through treatment. |
| Protein quality | AdequateNot the main lever for Type 1. | High qualityLysine and threonine focus. This is the lever for Type 2. | Adequate to highSupports muscle rebuilding during recovery. |
| Vitamin E | 1,000 to 2,000 IU/dayNatural-source alpha-tocopherol. | 2,000 to 5,000 IU/dayHigher antioxidant demand than Type 1. | 5,000 to 10,000 IU/dayDuring treatment, then taper. |
| Selenium | 1 to 3 mg/dayRegion-dependent. Get a forage selenium reading. | Region-titratedPair with vitamin E. They work together. | Region-titratedAntioxidant pairing matters during recovery. |
| Omega-3 EPA/DHA | OptionalModest evidence; nice-to-have, not a fix. | OptionalModest evidence; nice-to-have, not a fix. | Reasonable adjunctAnti-inflammatory rationale during recovery. |
| Meal pattern | Frequent small mealsPre-exercise NSC content matters. | Frequent small mealsLess critical than Type 1. | Maintain intakeSupportive feeding through treatment-related appetite loss. |
| What to monitor | CK, AST, BCSPlus an episode log kept by the owner. | Muscle biopsy when feasiblePlus muscle-mass tracking and CK. | Neurologic exam gradeCK during rehab. BCS matters during recovery. |
| First diagnostic step | GYS1 genetic testCheek swab or blood. Confirm before changing the diet. | Muscle biopsyPolygenic test panels (P2, P3, P4, K1, Px) remain controversial. | Paired serum/CSF antibodyPlus a graded neurologic exam. |
| Source reviews | 01, 02, 03, 09, 10, 26, 28 | 04, 05, 23, 24 | 11, 12, 22, 25, 27 |
Tying-up episode frequency in confirmed PSSM Type 1 horses, indexed against a conventional sweet-feed grain ration (= 100). The drop is steep between 15% and 10% NSC; below ten percent the curve flattens.
Synthesized from reviews 01, 02, 03, 09, 26. Approximate values; see source reviews for cohort-specific data.
Every recommendation here ties to a specific review below. Click any review number, read the methodology, decide for yourself. The full library is open and downloadable.
Each review opens its own page with the polished research thesis, what it contributes to the corpus, captured charts, the full rendered text with inline figures, IEEE references with hyperlinked DOIs, and a downloadable PDF that opens with the Foxwatch Statement of Method and Ownership.
Can diet alone control PSSM Type 1? The short answer is yes, and this is the review that demonstrates it. Reads every controlled feeding trial and observational study on horses with the confirmed GYS1 mutation, and shows that a low-sugar high-fat ration drops tying-up episodes, lowers muscle enzymes, and brings exercise tolerance back. If you only read one review on this site, read this one. Every other PSSM article cites it.
What number should the hay analysis come in below? This review reads every study that has tested sugar-and-starch ceilings in PSSM horses and lands on a defensible answer: under 10% for confirmed Type 1, under 12% as a working ceiling for less certain diagnoses. The hay calculator on this site runs straight off these thresholds. Read this with review 07 (which lab fraction to ask for) and review 08 (year-round forage strategy).
Pouring oil on top of grain is not a high-fat diet. This review explains what fat substitution actually means in a PSSM ration, which fat sources have evidence behind them (rice bran, vegetable oils, stabilized fat supplements), and why adding fat without removing carbohydrate just makes the horse fatter without helping the disease. Builds on review 01 (the foundation) and sets up review 17 (feeding the underweight PSSM horse).
If your horse keeps tying up but the GYS1 test came back negative, the answer is probably here. PSSM Type 2 and myofibrillar myopathy are different diseases from Type 1, with different causes, different muscle biology, and different feeding needs. A low-sugar diet alone often does not solve them. This review also walks through which "PSSM2 polygenic panels" actually have peer-reviewed validation, and which are still scientifically controversial. Read with reviews 05 (amino acids), 23 (trace minerals), and 28 (genetic testing).
For a Type 2 PSSM horse, protein quality is the lever, not carbohydrate restriction. This review explains why lysine, threonine, and the branched-chain amino acids matter so much for non-Type-1 muscle disease, and which supplements actually deliver them in usable form. The right next read for any owner stuck on a low-sugar plan that is not working. Builds on review 04 (the PSSM2 evidence map) and review 23 (trace minerals).
Two horses can both "tie up" and need completely different feeding plans. Recurrent Exertional Rhabdomyolysis is a calcium-handling problem in the muscle fiber, not a glycogen storage problem like PSSM. The high-fat low-sugar ration that controls PSSM is unhelpful for an RER horse, and the small-meal low-grain low-stress protocol that controls RER will leave a PSSM horse undertreated. This review tells the two apart so the diet matches the disease. Read with review 12 (when the diagnosis is unclear).
Every neurologic horse is not an EPM horse. Antibody seroprevalence in healthy horses runs higher than the actual rate of clinical EPM. Cervical vertebral compressive myelopathy, equine herpesvirus-1 myeloencephalopathy, equine motor neuron disease, and Lyme neuroborreliosis routinely look like EPM and respond to entirely different therapy. This review builds the differential-diagnosis tree veterinarians actually need, with paired serum/CSF testing, neurologic exam grading, and likelihood-ratio math. Drives the EPM differential matrix on the EPM page.
EPM treatment is hard on the horse. Antiprotozoal drugs run for weeks, appetite drops, oxidative stress climbs, and muscle mass slips. This review covers the supportive-care nutrition that keeps a horse eating, fighting that oxidative load, and holding muscle through ponazuril, diclazuril, or nitazoxanide. The acute-phase decisions are different from the rehab-phase decisions in review 22.
Acute EPM and rehab EPM are different feeding problems. Acute is about palatability, calorie density, and antioxidant load while the antiprotozoal runs. Rehab is about protein adequacy, body-condition recovery, and rebuilding muscle as the horse comes back into work. This review separates the two phases and writes the rehab-phase ration down. Pairs with reviews 11 (acute) and 27 (the mechanism story).
Pasture grass swings from safe to dangerous within a single afternoon. This review compiles the agronomic and equine-nutrition literature on diurnal sugar variation, hay storage, grass species, harvest stage, and grazing-restriction strategies, then turns it into a year-round forage plan. Owners who think "the hay is tested, turnout is fine" often miss the pasture half of the equation. Read with reviews 02 (sugar threshold) and 09 (meal timing).
When you feed matters almost as much as what you feed. Pasture grass sugar content rises through the day and falls overnight; a grain meal spikes glucose differently if the horse worked first or rested first; insulin response shifts with feeding interval. This review covers the diurnal sugar curve, post-prandial dynamics, and pre-exercise meal composition in horses already biased toward storing too much glycogen. Powers the time-of-day pasture chart on the feeding-PSSM page. Read with review 02 (threshold) and 08 (pasture management).
A "low-sugar" diet does not exempt a horse from being too fat. PSSM horses with metabolic syndrome have a worse time of it because the muscle is already insulin-sensitive and obesity drives the substrate load the diet is trying to restrict. This review integrates body-condition management, EMS screening, and PSSM dietary strategy into a single plan. Read with review 17 (the opposite problem, the underweight horse) and review 09 (meal timing).
Adding weight to a hard-keeper PSSM horse without breaking the low-sugar ration is a real problem most feed-store advice gets wrong. This review covers oils, stabilized rice bran, beet pulp, and the trade-offs around palatability, intake rate, gastric ulcer risk, and amino acid balance. Builds on review 03 (high-fat diets) and connects to review 33 (gastric ulcer risk).
How do you actually know the diet is working? This review identifies the small panel of labs that catches a failing protocol before the next tying-up episode: creatine kinase, AST, glutathione peroxidase, and serum vitamin E. Drives the recheck schedule and reference ranges in the feeding protocol. Read with review 01 (foundation) and review 24 (how strong this evidence really is).
Vitamin E and selenium have direct horse evidence. Most other "antioxidant" supplements have only mechanistic theory. This review grades each one by strength of evidence and helps you stop spending money on antioxidant blends that have never been tested in a horse. Pairs with review 15 (selenium specifically), 19 (other micronutrients), and 27 (the EPM antioxidant story).
Fish oil and algae are reasonable add-ons but not a fix. This review walks through the evidence for EPA and DHA in equine neuromuscular disease, explains why marine sources beat plant sources for horses, and shows which omega-3 products actually deliver what they advertise. A useful adjunct for the EPM rehab horse. Pairs with reviews 11 (acute EPM nutrition) and 13 (antioxidants).
The regional nutrient owners get wrong most often. The same selenium dose can be deficient in Pacific Northwest hay and toxic in Plains hay. This review explains why selenium status has to be region-titrated and why organic forms (selenized yeast, selenomethionine) outperform inorganic selenite or selenate. Covers the synergy with vitamin E, which is why dosing them separately is risky. Pairs with reviews 13 (antioxidants) and 19 (other micronutrients).
Beyond vitamin E and selenium, vitamin D, magnesium, B-complex, copper, zinc, iron, and chromium each carry small but real risk or benefit during muscle and neurologic recovery. This review tiers them by evidence strength so you can build a complete supplement plan instead of stacking three blends and hoping. Pairs with reviews 13 (antioxidants) and 23 (trace minerals in PSSM2).
PSSM Type 2 and MFM horses are not just Type 1 horses with a less strict diet. The biopsy-defined oxidative stress and protein aggregation profile is different, and a ration balancer chosen for a Type 1 horse routinely under-delivers calcium, phosphorus, magnesium, copper, and zinc to a Type 2 horse. This review writes trace-mineral targets specifically for non-GYS1 muscle disease. Builds on reviews 04 (PSSM2 evidence map) and 05 (amino acids).
PSSM and EPM treatment both reshape the hindgut. High-fat low-sugar rations, antiprotozoal drugs, and prolonged stall rest each change which microbes live in the cecum, and dysbiosis there can swing systemic inflammation in ways that affect both diseases. This review maps where direct equine evidence exists and where current "gut support" marketing is speculation. Pairs with review 33 (gastric ulcer comorbidity).
Some horses have both diseases. The high-fat low-sugar ration that controls PSSM raises the gastric ulcer and antioxidant-demand concerns most relevant to EPM recovery. Antiprotozoal treatment changes muscle protein turnover in ways the single-disease guidance does not anticipate. This review reconciles the two protocols so you do not solve one disease and worsen the other. Pairs with reviews 11 (EPM nutrition) and 22 (EPM rehab).
High-fat low-sugar PSSM rations and antiprotozoal-plus-corticosteroid EPM protocols both raise gastric ulcer and hindgut acidosis risk. EGUS prevalence already exceeds 60% in performance horses before any disease modifier is added. This review folds GI-protective management into the disease-specific protocols so you do not solve one problem and create another. Pairs with reviews 17 (underweight PSSM) and 20 (gut microbiome).
The single most important lab decision in PSSM management. The same bale of hay can come back "PSSM-safe" or "unsafe" depending on whether the lab reports ESC, WSC, total NSC, or starch. This review explains what each fraction actually measures, which one predicts whether your horse will tie up, and how to pick one and stay with it across rechecks so trend lines mean something. Pairs with review 02 (the threshold) and review 31 (commercial feed database).
How strong is the evidence behind "low-sugar works"? This review applies a formal risk-of-bias framework to every PSSM nutrition trial in the corpus and grades them honestly. The dietary management evidence is moderate to strong, but it is not Cochrane-tier, and several headline conclusions overstate the certainty. Read this before you tell an owner "the science says." Pairs with review 25 (the EPM equivalent).
The EPM treatment evidence is solid. The EPM nutritional supportive-care evidence is much weaker, and most current recommendations rest on mechanistic inference rather than direct trials. This review grades the supportive-care literature, names the priority studies the field needs next, and stops anyone from overstating the certainty of "EPM nutrition" claims. Pairs with reviews 11 (acute nutrition) and 24 (the PSSM equivalent).
Why does low-sugar feeding actually work? This review reads the molecular biology of the GYS1 mutation, explains how a low-sugar high-fat ration shifts skeletal muscle toward fatty acid oxidation, and connects each clinical recommendation back to its underlying biochemistry. Useful for veterinarians explaining the disease to owners and for owners who want the science behind the rules. Pairs with reviews 01 (foundation) and 03 (high-fat).
Sarcocystis neurona invades the central nervous system, and the secondary inflammation does most of the lasting damage. This review maps which nutrients (vitamin E, selenium, omega-3, protein adequacy) act on which CNS injury mechanisms, and which "EPM nutrition support" claims are mechanistically supported versus speculative. Pairs with reviews 11 (acute) and 22 (rehab).
Pulls all 34 reviews into one decision tree. Confirmed PSSM Type 1, suspected PSSM2, confirmed EPM, suspected EPM, overlapping signs, uncertain diagnosis: each branch has its own diagnostic, dietary, and monitoring path. Veterinarians and barn managers building a feeding plan against a real diagnosis use this review as the master flow. Cross-references every other review on the site.
Six-month trial results are not the same as five-year management. Return-to-work rates, episode-frequency reduction, owner-reported quality of life, and survival data evolve substantially after the first six months and live mostly in retrospective cohorts and owner surveys. This review pulls the long-horizon data forward so owners can plan past the first year. Pairs with review 32 (cost of care).
Most feed bags marketing themselves as "PSSM-safe" are not validated for PSSM. This review audits the published evidence behind named feeds and supplement formulations and sorts products into evidence tiers: independently validated, manufacturer-supported, formulation analogy, or testimonial only. Bring it to the feed store. Pairs with review 31 (full feed composition database) and review 07 (forage testing).
Brand-by-brand commercial feed composition turned into something owners can actually compare. NSC, fat, protein, fiber, and price across the major US, UK, EU, and Australian manufacturers, with each product sorted into a PSSM-suitability tier. The data source for filterable feed comparison tools on this site. Pairs with review 02 (sugar threshold) and review 18 (commercial feed claim audit).
PSSM and EPM are expensive diseases, and most owners only see the direct costs (feed, supplements, vet bills) and not the indirect ones (lost competition value, retraining, retirement). This review projects five-year costs by disease severity tier across US, UK, EU, and Australian regions, and runs the cost-effectiveness math on dietary intervention versus standard care. Pairs with review 18 (commercial feed audit) and 30 (long-term outcomes).
"Equine nutritionist" is barely a regulated title in any major jurisdiction. This review maps the credentialing landscape across the US, UK, EU, and Australia, exposes which "consultants" hold real qualifications versus marketing titles, and proposes the four-tier credentialing framework this site uses for sponsor disclosure: board-certified DACVN, PhD-level academic, industry-certified, and commercial. The structural reason every Foxwatch sponsor credential is visible on every page they touch.
The cheapest and most informative diagnostic step in the PSSM workflow, and the one most often skipped. This review walks through the testing-laboratory landscape (UC Davis, Animal Genetics, Etalon, EquiSeq), breed-specific carrier frequencies, the pre-breeding decision, and the live scientific controversy over the marketed "PSSM2 polygenic panels." Read with reviews 01 (PSSM foundation) and 04 (PSSM2 evidence map).